These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27539972)

  • 21. Paediatric heart failure research: role of the National Heart, Lung, and Blood Institute.
    Burns KM
    Cardiol Young; 2015 Aug; 25 Suppl 2():167-71. PubMed ID: 26377724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vascular surgeon-scientist: a 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program.
    Kibbe MR; Dardik A; Velazquez OC; Conte MS;
    J Vasc Surg; 2015 Apr; 61(4):1050-7. PubMed ID: 25814368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review.
    Oldham WM; Hemnes AR; Aldred MA; Barnard J; Brittain EL; Chan SY; Cheng F; Cho MH; Desai AA; Garcia JGN; Geraci MW; Ghiassian SD; Hall KT; Horn EM; Jain M; Kelly RS; Leopold JA; Lindstrom S; Modena BD; Nichols WC; Rhodes CJ; Sun W; Sweatt AJ; Vanderpool RR; Wilkins MR; Wilmot B; Zamanian RT; Fessel JP; Aggarwal NR; Loscalzo J; Xiao L
    J Am Coll Cardiol; 2021 Apr; 77(16):2040-2052. PubMed ID: 33888254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025.
    Kiley J; Mockrin S; Lauer M; Mensah GA; Hoots K; Patel Y; Cook NL; Patterson AP; Gibbons GH
    Am J Respir Crit Care Med; 2015 Mar; 191(5):489-91. PubMed ID: 25706106
    [No Abstract]   [Full Text] [Related]  

  • 25. Initial Outcomes for the NHLBI K99/R00 Pathway to Independence Program in Relation to Long-Standing Career Development Programs: Implications for Trainees, Mentors, and Institutions.
    Carlson DE; Wang WC; Scott JD
    Circ Res; 2016 Sep; 119(8):904-8. PubMed ID: 27688307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Support for cardiovascular cell therapy research at the National Heart, Lung, and Blood Institute.
    Buxton DB; Skarlatos SI
    Circ Res; 2012 Jun; 110(12):1549-55. PubMed ID: 22679137
    [No Abstract]   [Full Text] [Related]  

  • 27. Critical Challenges and Compelling Questions for Chronic Obstructive Pulmonary Disease. Moving the Field Forward: A National Heart, Lung, and Blood Institute Perspective.
    Postow L
    Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S282-S284. PubMed ID: 30759012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notes from the Director, National Heart, Lung, and Blood Institute: NHLBI core values and shaping the 2007 budget.
    Nabel EG; Shurin SB
    Circulation; 2007 Aug; 116(6):683-4. PubMed ID: 17679630
    [No Abstract]   [Full Text] [Related]  

  • 29. Report of the National Heart, Lung, and Blood Institute Working Group on Sex Differences Research in Cardiovascular Disease: Scientific Questions and Challenges.
    Maric-Bilkan C; Arnold AP; Taylor DA; Dwinell M; Howlett SE; Wenger N; Reckelhoff JF; Sandberg K; Churchill G; Levin E; Lundberg MS
    Hypertension; 2016 May; 67(5):802-7. PubMed ID: 26975706
    [No Abstract]   [Full Text] [Related]  

  • 30. Shaping the future of research: the NHLBI strategic plan.
    Nabel EG
    Blood; 2007 Dec; 110(13):4143. PubMed ID: 18056844
    [No Abstract]   [Full Text] [Related]  

  • 31. NHLBI announces SMARTT program.
    J Investig Med; 2011 Jun; 59(5):744. PubMed ID: 22121528
    [No Abstract]   [Full Text] [Related]  

  • 32. An analysis of the NIH-supported sickle cell disease research portfolio.
    Gavini N; Hoots WK; Mensah GA; Hanspal M
    Blood Cells Mol Dis; 2015 Feb; 54(2):198-205. PubMed ID: 25466208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiothoracic surgery and the National Institutes of Health and National Heart, Lung, and Blood Institute.
    LaPar DJ; Kron IL
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):20-3. PubMed ID: 21683836
    [No Abstract]   [Full Text] [Related]  

  • 34. On the value of portfolio diversity in heart, lung, and blood research.
    Galis ZS; Hoots WK; Kiley JP; Lauer MS
    Circ Res; 2012 Sep; 111(7):833-6. PubMed ID: 22891047
    [No Abstract]   [Full Text] [Related]  

  • 35. The Productivity of NHLBI-Funded Obesity Research, 1983-2013.
    Nicastro HL; Belter CW; Lauer MS; Coady SA; Fine LJ; Loria CM
    Obesity (Silver Spring); 2016 Jun; 24(6):1356-65. PubMed ID: 27145059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National Heart, Lung, and Blood Institute: transitions.
    Nabel EG
    Circulation; 2009 Mar; 119(10):1453-5. PubMed ID: 19289650
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic obstructive pulmonary disease: a view from the NHLBI.
    Punturieri A; Croxton TL; Weinmann GG; Kiley JP
    Am J Respir Crit Care Med; 2008 Sep; 178(5):441-3. PubMed ID: 18713849
    [No Abstract]   [Full Text] [Related]  

  • 38. Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities.
    Shurin SB
    Circulation; 2011 Oct; 124(17):1894-6. PubMed ID: 22025639
    [No Abstract]   [Full Text] [Related]  

  • 39. The ambitions and goals of the National Heart, Lung, and Blood Institute at The National Institute of Health.
    Eur Heart J; 2009 May; 30(10):1155-6. PubMed ID: 19443422
    [No Abstract]   [Full Text] [Related]  

  • 40. Toward Independence: Resubmission Rate of Unfunded National Heart, Lung, and Blood Institute R01 Research Grant Applications Among Early Stage Investigators.
    Boyington JE; Antman MD; Patel KC; Lauer MS
    Acad Med; 2016 Apr; 91(4):556-62. PubMed ID: 26650674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.